Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1999-08-04
Original market date: See footnote 1
1994-12-31
Product name:
LENTARON
DIN:
02128209 Electronic product monograph is not available
Company:
NOVARTIS PHARMACEUTICALS CANADA INC
100
700 Rue Saint-Hubert
Montreal
Quebec
Canada
H2Y 0C1
Class:
Human
Dosage form(s):
Powder For Solution , Liquid
Route(s) of administration:
Intramuscular
Number of active ingredient(s):
2
Schedule(s):
PRESCRIPTION
Anatomical Therapeutic Chemical (ATC): See footnote 4
L02BG02 FORMESTANE
Active ingredient group (AIG) number:See footnote5
0226698001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| FORMESTANE | 250 MG / KIT |
| SODIUM CHLORIDE | .9 % / KIT |